LANXESS Aktiengesellschaft (SWX:LXS)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 1.12B -44.8% |
| Revenue (ttm) | 5.12B -9.8% |
| Net Income | -617.56M |
| EPS | -7.15 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 17.78 |
| Dividend | 0.09 (0.62%) |
| Ex-Dividend Date | May 22, 2026 |
| Volume | n/a |
| Open | n/a |
| Previous Close | 14.82 |
| Day's Range | n/a |
| 52-Week Range | 10.92 - 19.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |
About SWX:LXS
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the ag... [Read more]
Financial Performance
In 2025, SWX:LXS's revenue was 5.67 billion, a decrease of -10.89% compared to the previous year's 6.37 billion. Losses were -577.00 million, 226.0% more than in 2024.
Financial numbers in EUR Financial StatementsNews
LANXESS Aktiengesellschaft Earnings Call Transcript: Q2 2026
Q2 saw strong sequential EBITDA and cash flow growth, driven by tight working capital and cost controls. Full-year guidance is maintained, with Q3 expected to be softer than Q2 but above last year. Structural cost actions and a successful bond issue support ongoing deleveraging.
LANXESS Aktiengesellschaft Quarterly report: Q2 2026
LANXESS Aktiengesellschaft has published its Q2 2026 quarterly earnings report on August 7, 2026.
LANXESS Aktiengesellschaft Slides: Q2 2026
LANXESS Aktiengesellschaft has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
LANXESS Aktiengesellschaft Earnings release: Q2 2026
LANXESS Aktiengesellschaft released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
LANXESS Aktiengesellschaft Q2 Earnings Call Highlights
LANXESS Aktiengesellschaft ETR: LXS reported stronger sales and earnings in the second quarter of 2026 than in the first quarter, supported by improved volumes, pricing and demand effects linked to th...
LANXESS Aktiengesellschaft Earnings Call Transcript: Q2 2026
Q2 2026 saw strong sequential growth in sales and EBITDA, with positive free cash flow and all segments contributing. Despite logistical challenges from low Rhine water levels and ongoing economic headwinds, full-year guidance is confirmed, supported by cost discipline and EU anti-dumping measures.
LANXESS Aktiengesellschaft Earnings release: Q2 2026
LANXESS Aktiengesellschaft released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
EU to impose provisional duties on Chinese sodium benzoate
The European Union will impose provisional anti-dumping duties on imports from Chinese producers of sodium benzoate after an investigation sparked by a complaint from German chemicals group Lanxess re...
EQS-PVR: LANXESS Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: LANXESS Aktiengesellschaft LANXESS Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of ...
Lanxess price target lowered to EUR 17.50 from EUR 19 at Citi
Citi lowered the firm’s price target on Lanxess (LNXSF) to EUR 17.50 from EUR 19 and keeps a Neutral rating on the shares.
Lanxess downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs downgraded Lanxess (LNXSF) to Sell from Neutral with a price target of EUR 13, down from EUR 21. The Middle East conflict has raised questions around the company’s…
Lanxess downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Lanxess (LNXSF) to Neutral from Overweight with an EUR 18 price target as part of a broader sector note on European Chemicals. The firm sees limited absolute upside…
LANXESS Aktiengesellschaft Transcript: AGM 2026
Amid a challenging market, sales and EBITDA declined, but debt was halved and liquidity remains strong. Strategic restructuring, cost-saving programs, and sustainability initiatives are underway, with a stable dividend proposed and cautious optimism for future recovery.
Lanxess downgraded to Underperform from Hold at Jefferies
Jefferies downgraded Lanxess (LNXSF) to Underperform from Hold with a price target of EUR 16, down from EUR 17. The firm cites the 53% share price rally from the March…
LANXESS Aktiengesellschaft Earnings Call Transcript: Q1 2026
Q1 2026 saw a slow start but improved momentum in March, with Q2 expected to show strong sequential gains driven by both volume and pricing. Full-year guidance is maintained, supported by cost savings and positive segment trends, though geopolitical risks remain.
LANXESS Aktiengesellschaft Slides: Q1 2026
LANXESS Aktiengesellschaft has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
LANXESS Aktiengesellschaft Quarterly report: Q1 2026
LANXESS Aktiengesellschaft has published its Q1 2026 quarterly earnings report on May 7, 2026.
LANXESS Aktiengesellschaft Earnings release: Q1 2026
LANXESS Aktiengesellschaft released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
LANXESS Aktiengesellschaft Earnings Call Transcript: Q1 2026
Q1 2026 saw sales and EBITDA decline sharply year-over-year, but March brought improving demand and volumes. Full-year EBITDA guidance is maintained, with price increases underway and cost discipline in focus amid ongoing geopolitical and supply chain risks.
LANXESS Aktiengesellschaft Quarterly report: Q1 2026
LANXESS Aktiengesellschaft has published its Q1 2026 quarterly earnings report on May 7, 2026.
LANXESS Aktiengesellschaft Earnings release: Q1 2026
LANXESS Aktiengesellschaft released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Lanxess downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley downgraded Lanxess (LNXSF) to Equal Weight from Overweight with a price target of EUR 20, down from EUR 26. The firm adjusted ratings in the European industrial chemicals…
Lanxess upgraded to Overweight from Underweight at JPMorgan
JPMorgan analyst Chetan Udeshi double upgraded Lanxess (LNXSF) to Overweight from Underweight with a price target of EUR 18, up from EUR 15. The company’s “disruption tailwinds” and cost savings…
LANXESS Aktiengesellschaft Earnings Call Transcript: Q4 2025
Full-year EBITDA met guidance at €510 million, with net debt reduced and strong liquidity maintained. 2026 outlook remains cautious amid geopolitical and market volatility, but cost savings and portfolio focus position the company for recovery if volumes improve.
LANXESS Aktiengesellschaft Annual report: Q4 2025
LANXESS Aktiengesellschaft has published its Q4 2025 annual report on March 19, 2026.